Madagascar
Schools and hotels in Madagascar are being transformed into hospitals as coronavirus cases surge on the Indian Ocean island.
The spike is most likely due to the South African variant, which has caused a second wave.
But as hospitals are overwhelmed, the makeshift treatment centres are also quickly getting full.
Hotels too are being used for the influx of patients as hospitals are overwhelmed.
"We came here yesterday and there were still places available but now it's almost full," said caretaker Narinda.
Madagascar's President was against Covid vaccines and stood by a locally made herbal infusion as a "cure".
Vaccine U-turn
But last week the country joined the Covax programme.
Madagascar President Andry Rajoelina was initially strongly against Covid vaccines and stood by a locally made herbal infusion as a cure.
But after fierce criticism, the government took a U-turn and signed up for the global Covax programme.
"We had discussions, exchanges with Malagasy scientists and then we decided to go for vaccination," said health minister Jean-Louis Rakotovao.
"This is another way to protect the population."
Herbal "cure"
The vaccination programme has yet to start and the government is still pushing its herbal infusion, which is based on the anti-malarial plant artemisia.
Dubbed Covid-Organics or CVO, it is sold in drink and capsule form and has been widely distributed to citizens.
Experts have cautioned against the brew, which has not been scientifically tested.
Madagascar, an island of around 27 million inhabitants, has recorded more than 24,600 coronavirus cases, including at least 433 deaths.
Go to video
Egypt pledges 30 mln COVID-19 vaccine doses to African states
01:28
Ghana prepares to face Madagascar for AFCON qualifier
Go to video
South Africa fears new surge driven by variants
Go to video
Ramaphosa and counterparts to save Africa’s first covid-19 vaccine plant from closure
01:07
Africa's first Covid vaccine plant risks closure after no orders
Go to video
COVID 19 cases, deaths in Africa drop to lowest levels yet - WHO